Substance-use disorder biotech Tempero Bio shuts down after serious safety incident
read at Endpoints ↗Negative
Tempero Bio, a biotech focused on treatments for substance use disorders, announced it will cease operations.
The decision follows a serious adverse event that occurred during the company's development program, prompting concerns about safety.
The closure ends the company's efforts to bring new therapies for addiction to market and underscores the challenges biotech firms face in advancing such treatments.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Substance use disorder biotech Tempero to close after earlier 'serious' safety event”
read at Endpoints ↗87 words · retrieved Apr 26
comments(0)
5-min edit window · permanent after that